Skip to main content

Featured

Six Days Adrift: Tragedy Strikes Migrant Boat off Greek Coast

  Twenty-two migrants lost their lives off the coast of Greece after spending six harrowing days at sea in a rubber boat that had departed from Tobruk, Libya. According to survivor accounts and Greek coastguard reports, the passengers became disoriented during the journey and were left without food or water, leading to fatal exhaustion.  Rescue teams recovered 26 survivors, including a woman and a minor, near the island of Crete. Several survivors reported that the bodies of those who died were thrown overboard on the orders of smugglers accompanying the group. Greek authorities have since arrested two South Sudanese men, aged 19 and 22, suspected of human trafficking and negligent homicide.  The tragedy highlights the ongoing dangers faced by migrants attempting to reach Europe via the Mediterranean, a route that continues to claim lives despite increased border controls and international attention. Poor weather, overcrowded vessels, and lack of supplies remain persis...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment